To the best of our knowledge, there have been no reports about HDAC1/miR-200b/Suz-12/E-cadherin regulatory network in regulating CSCs maintenance and chemoresistance in human LAD cells and the current work will provide a novel strategy for reversing chemoresistance of human LAD. This evidence concerns the gene HDAC1 and leukocyte adhesion deficiency.